Hospital resources for urokinase/recombinant tissue-type plasminogen activator therapy for acute stroke in Beijing
Surgical Neurology · 2009-08 · 72 · S2-S7
DOI: 10.1016/j.surneu.2007.12.028 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Surgical Neurology, 2009-08. Verfasst von Yilong Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, China. yilong528@gmail.com. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 12 Literaturangaben. Gefördert von: Beijing Municipal Science and Technology Commission, Key Technologies Research and Development Program.
Themen: Schlaganfall
Abstract (Originalsprache)
BACKGROUND: We focus on the current resource level for UK/rt-PA therapy in hospitals in Beijing to design strategies for improving treatment for stroke patients. METHODS: The data were collected through surveys of 124 grade II or higher hospitals in Bejing, which provide stroke treatment, from July to September 2006. RESULTS: Of the surveyed hospitals, 50% and 92.6% were capable in providing intravenous UK/rt-PA treatment and head CT service, respectively. Eight (7.4%) hospitals have specialized stroke units and 106 (98.1%) hospitals have EDs. We found significant differences between hospitals that can provide UK/rt-PA therapy and the hospitals that cannot in the levels of specialists and clinical care capacity as follows: CT (100% vs 85.2%; P = 0.01), CTA (46.3% vs 22.2%; P = .014), MRI (66.7% vs 22.2%; P = .000), MRA (57.4% vs 20.4%; P = .000), DWI (48.1% vs 9.3%; P = .000), PWI (31.5% vs 5.6%; P = .001), DSA (63.0% vs 25.9%; P = .000), neurologists (100% vs 79.6%; P = .001), neurosurgeons (75.9% vs 44.4%; P = .002), carotid stenting (33.3% vs 5.6%; P = .000), stroke unit (14.8% vs 0%; P = .01), and acute stroke care system (31.5% vs 0%; P = .000). CONCLUSION: The thrombolysis treatment facilities in Beijing are not sufficient. Hospitals in Beijing should organize stroke-related medical sources.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, China. yilong528@gmail.com
Förderung
- Beijing Municipal Science and Technology Commission
- Key Technologies Research and Development Program
Zitieren
APA
Wang, Y., Wu, D., Zhao, X., Ma, R., Guo, X., Wang, C., Liu, L., Zhao, W., & Wang, Y. (2009). Hospital resources for urokinase/recombinant tissue-type plasminogen activator therapy for acute stroke in Beijing. Surgical Neurology, 72, S2-S7. https://doi.org/10.1016/j.surneu.2007.12.028
Vancouver
Wang Y, Wu D, Zhao X, Ma R, Guo X, Wang C, et al. Hospital resources for urokinase/recombinant tissue-type plasminogen activator therapy for acute stroke in Beijing. Surgical Neurology. 2009;72:S2-S7. doi:10.1016/j.surneu.2007.12.028
BibTeX
@article{Wang2009,
author = {Wang, Yilong and Wu, Di and Zhao, Xingquan and Ma, Ruihua and Guo, Xiangping and Wang, Chunxue and Liu, Liping and Zhao, Weijiang and Wang, Yongjun},
title = {Hospital resources for urokinase/recombinant tissue-type plasminogen activator therapy for acute stroke in Beijing},
journal = {Surgical Neurology},
year = {2009},
volume = {72},
pages = {S2--S7},
doi = {10.1016/j.surneu.2007.12.028}
}
EUVIMED